Bjorn Erik Christensen

Title: Bjorn Erik Christensen: Innovator in Gene Delivery Systems

Introduction

Bjorn Erik Christensen is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of gene delivery systems. His innovative work focuses on enhancing the efficiency of delivering nucleic acids into targeted cells.

Latest Patents

Christensen holds a patent for a non-viral gene delivery system. This invention involves a composition comprising complexes of cationic chitosan oligomers derived from the cationic polysaccharide chitosan. The cationic oligomers contain a weight fraction of less than 20% of oligomers with a Degree of Polymerization (DP) less than 10, in addition to a weight fraction of less than 20% with DP greater than 50, along with a nucleic acid. These compositions are advantageous for achieving the delivery of nucleic acids into selected tissue cells and obtaining in vivo expression of the desired molecules encoded by the nucleic acid.

Career Highlights

Christensen is associated with Fmc Biopolymer AS, where he continues to advance his research and development efforts. His work has the potential to impact various applications in medicine and biotechnology.

Collaborations

He has collaborated with notable colleagues, including Per Artursson and Magnus Koping-Hoggard, to further enhance the research in gene delivery systems.

Conclusion

Bjorn Erik Christensen's innovative contributions to gene delivery systems exemplify the importance of research in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.